Low and Moderete Flow Anaesthesia on Haemodynamics

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age17-70
SponsorUmraniye Education and Research Hospital

About this trial

The study topic investigates the potential advantages of low-flow anesthesia in terms of physiological protection and resource saving.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

being ASA1-2 status

between the ages of 18-70

who are planned for laparoscopic cholecystectomy

Disqualifiers

Patients who refuse to give informed consent

Pregnant and breastfeeding patients

Morbidly obese patients (Body mass index over 40)

Patients with uncontrolled diabetes mellitus, with serious cardiovascular, pulmonary, renal, hepatic disease, obstructive sleep apnea, with electrolyte imbalance- Those with a history of alcohol or drug abuse, with perioperative hemodynamic instability

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sevoflurane (Volatile Anesthetic)

    Device

    Both groups will be given sevoflurane and one group will be given low current anesthesia and the other group will be given medium flow anesthesia.

  • low- medium flow anesthetic machine

    Device

    The study aims to compare the effects of low and normal flow sevoflurane anesthesia on the frontal QRS-T angle and cerebral oxygenation in laparoscopic cholecystectomy surgery.

Treatment groups

76 Participants
are divided into 2 treatment groups
Group A: low flow anesthesiaActive comparator 2 interventions
Group B: Medium Flow AnesthesiaActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

the effects of low-flow anesthesia on hemodynamic stability

The primary objective was to detect the adverse effects of low-flow anesthesia on hemodynamic stability and arrhythmia risk

Time frame
in 2 months

Secondary outcomes

1

the cerebral oxygenation

The primary objective was to detect the adverse effects of low-flow anesthesia on cerebral oxygenation

Time frame
in 2 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: